ITU Unit Action

PRESTIGE

Osiris Therapeutics, Inc.

ITU Unit Action

Trademark Snap Shot ITU Unit Action
(Table presents the data on ITU Unit Action)

OVERVIEW

SERIAL NUMBER 87346749 FILING DATE 02/23/2017
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE SERVICE MARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY SMIGA, HOWARD
L.O. ASSIGNED 102

PUB INFORMATION

RUN DATE 07/07/2018
PUB DATE 11/14/2017
STATUS 730-FIRST EXTENSION - GRANTED
STATUS DATE 07/05/2018
LITERAL MARK ELEMENT PRESTIGE

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT PRESTIGE
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 20-OWNER AT PUBLICATION
NAME Osiris Therapeutics, Inc.
ADDRESS 7015 Albert Einstein Drive
Columbia, MD 21046
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

GOODS AND SERVICES

INTERNATIONAL CLASS 040
          DESCRIPTION TEXT Lyopreservation of human tissue
INTERNATIONAL CLASS 044
          DESCRIPTION TEXT Processing of human tissue with viable cells for medical purposes

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 040 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 044 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
07/07/2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED 020
07/05/2018 EX1G S EXTENSION 1 GRANTED 019
07/05/2018 EXT1 S EXTENSION 1 FILED 018
07/05/2018 EEXT I TEAS EXTENSION RECEIVED 017
01/09/2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT 016
11/14/2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED 015
11/14/2017 PUBO A PUBLISHED FOR OPPOSITION 014
10/25/2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED 013
10/06/2017 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED 012
10/04/2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 011
10/04/2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 010
10/04/2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 009
09/27/2017 ALIE A ASSIGNED TO LIE 008
09/20/2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 007
03/22/2017 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 006
03/22/2017 GNRT F NON-FINAL ACTION E-MAILED 005
03/22/2017 CNRT R NON-FINAL ACTION WRITTEN 004
03/22/2017 DOCK D ASSIGNED TO EXAMINER 003
03/02/2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
02/27/2017 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Jamie B. Bischoff
CORRESPONDENCE ADDRESS JAMIE B. BISCHOFF
1735 MARKET STREET, 51ST FLOOR
BALLARD SPAHR LLP
PHILADELPHIA, PA 19103-7599
DOMESTIC REPRESENTATIVE NONE

PRIOR OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Osiris Therapeutics, Inc.
ADDRESS 7015 Albert Einstein Drive
Columbia, MD 21046
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

ITU Unit Action [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed